Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
The Journal of Clinical Endocrinology and Metabolism
|
March 13, 2008
Evidence for acyl-ghrelin modulation of growth hormone release in the fed state
Ralf Nass, Leon S Farhy, Jianhua Liu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 20, 2008
Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men
Jianhua Liu, Catherine E Prudom, Ralf Nass, et al.
Diabetes Research and Clinical Practice
|
December 11, 2025
Human factors in the use and efficacy of decision support technologies for type 1 diabetes: evidence from a randomized controlled trial
Jacopo Pavan, Ralf Nass, Chiara Fabris, et al.
Diabetes Technology & Therapeutics
|
February 6, 2026
Safety and Feasibility of Algorithmic Continuous Glucose Monitoring-Based Titration in People with Type 2 Diabetes Using Insulin Degludec, With or Without Noninsulin Glucose-Lowering Drugs: A 16-Week Randomized Controlled Trial
Anas El Fathi, Ralf Nass, Carol J Levy, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
The Journal of Clinical Endocrinology and Metabolism
|
March 13, 2008
Evidence for acyl-ghrelin modulation of growth hormone release in the fed state
Ralf Nass, Leon S Farhy, Jianhua Liu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 20, 2008
Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men
Jianhua Liu, Catherine E Prudom, Ralf Nass, et al.
Diabetes Research and Clinical Practice
|
December 11, 2025
Human factors in the use and efficacy of decision support technologies for type 1 diabetes: evidence from a randomized controlled trial
Jacopo Pavan, Ralf Nass, Chiara Fabris, et al.
Diabetes Technology & Therapeutics
|
February 6, 2026
Safety and Feasibility of Algorithmic Continuous Glucose Monitoring-Based Titration in People with Type 2 Diabetes Using Insulin Degludec, With or Without Noninsulin Glucose-Lowering Drugs: A 16-Week Randomized Controlled Trial
Anas El Fathi, Ralf Nass, Carol J Levy, et al.
Page
of 3